STAT

AUGUST 15, 2024

WASHINGTON — The day drug makers dreaded has finally arrived.  Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them.  The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl

Drug Pricing 363

Drug Pricing Diabetes 363

PharmaVoice

AUGUST 15, 2024

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

240

240

STAT

AUGUST 15, 2024

Modern medicine has an empathy problem. Artificial intelligence — done right — might be able to help ease it. Despite the proliferation of communication training programs over the past decade or two, doctors often fail to express empathy, especially in stressful moments when patients and their families are struggling to hear bad news and make difficult decisions.

Communication 358

Communication 358

PharmaVoice

AUGUST 15, 2024

The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.

Drug Pricing 130

Drug Pricing 130

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

AUGUST 15, 2024

As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira. When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications such as Humira and Xeljanz become unaffordable overnight, thanks to the program’s convoluted pricing of at

Hospitals 356

Hospitals Drug Pricing 356

BioPharma Dive

AUGUST 15, 2024

The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.

Drug Pricing 120

Drug Pricing 120

World Pharma News

AUGUST 15, 2024

The U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds). "Today's approval provides the first epinephrine product for the treatment of anaphylaxis that is not administered by injection.

110

110

STAT

AUGUST 15, 2024

The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial. The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe.

363

363

The Pharmacist

AUGUST 15, 2024

The National Pharmacy Association (NPA) is ‘hopeful’ about the new government’s support for the sector, but is planning another day of action to keep pharmacy ‘on the agenda’. ‘The new government has had lots of issues to deal with in its first few weeks. We want to make sure that we remind the government this […] The post Paul Rees: 'We have to keep pharmacy on the government's agenda' appeared first on The Pharmacist.

109

109

STAT

AUGUST 15, 2024

When demand for office space cratered during the Covid-19 pandemic, many developers in the Boston area doubled down on building lab space instead. Lately, it sure seems like they went overboard. With life sciences buildings hitting the market at a much faster rate than they can be filled, the region’s lab vacancy rate has skyrocketed, to the point that the share of empty space available rivals that of the pandemic-battered office market.

326

326

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

AUGUST 15, 2024

The layoffs are part of a larger reorganization that will also see the departure of Lykos’ founder, the psychedelics advocate Rick Doblin.

120

120

STAT

AUGUST 15, 2024

Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by U.S. regulators, announced Thursday that it would cut 75% of its staff, and that the company’s founder would step down from its board. “We take to heart the FDA’s decision and the additional work we will need to do to bring this pioneering therapy to market,” Jeff George, chairman of the board, said in a statement.

315

315

pharmaphorum

AUGUST 15, 2024

FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.

107

107

STAT

AUGUST 15, 2024

The U.S. Department of Health and Human Services has stated it will do all that it can to mitigate the health care industry’s greenhouse gas emissions. The evidence suggests it is climate washing. Climate washing is defined as a government or business providing inadequate, inaccurate, misleading, or false public information about its climate policy ambitions or implementation efforts to reduce greenhouse gas emissions, especially when the claims are made without independent third-party as

Communication 315

Communication 315

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

AUGUST 15, 2024

Romaco Holding GmbH has announced the appointment of Jochen Schmidt as the new Managing Director of Romaco Pharmatechnik GmbH. Schmidt will oversee the company’s production site in Karlsruhe, Germany, where over 200 employees manufacture pharmaceutical machinery under the Noack and Siebler brands. “Jochen Schmidt is an extremely experienced and internationally recognised manager, and we’re delighted to have him on board as Managing Director of Romaco Pharmatechnik GmbH”, stated Jens Tork

103

103

STAT

AUGUST 15, 2024

A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork of disrupted access across multiple states.  UnitedHealthcare is the country’s largest health insurer, so its contract disagreements with large health systems affect members across the country from one another, threatening access to dozens of hospitals and their affiliated physicians.

Hospitals 297

Hospitals 297

The Pharmacist

AUGUST 15, 2024

The UK Health Security Agency (UKHSA) has updated its guidance to advise health professionals to be aware of a new more fatal variant of mpox, currently spreading in parts of central and East Africa. The UKHSA warning, issued today, comes after the World Health Organization (WHO) declared mpox a global public health emergency yesterday. There are […] The post UKHSA updates mpox guidance for health professionals amid global health alert appeared first on The Pharmacist.

94

94

STAT

AUGUST 15, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Big news this morning, so let’s get straight into it.

Vaccines 292

Vaccines Drug Pricing Drug Development 292

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 15, 2024

AI's role in inventing new drugs raises questions about ownership rights in the pharmaceutical sector. Explore the complexities of defining ownership in drug discovery with AI technology.

113

113

STAT

AUGUST 15, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Almost exactly two years ago, the Inflation Reduction Act was signed into law, allowing Medicare to negotiate drug prices for the first time. Today, the agency announced how much it lowered the costs for 10 drugs in the first year of negotiation.

Drug Pricing 280

Drug Pricing 280

Outsourcing Pharma

AUGUST 15, 2024

Tonix Pharmaceuticals has announced promising phase 3 trial results for TNX-102 SL (sublingual cyclobenzaprine HCl), a treatment targeting fibromyalgia.

99

99

STAT

AUGUST 15, 2024

Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.

Drug Pricing 274

Drug Pricing 274

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Technology

AUGUST 15, 2024

Strong measures must be in place to safeguard confidential patient data when deploying AI to optimise clinical trial translations.

107

107

Express Pharma

AUGUST 15, 2024

The U.S. Food and Drug Administration approved AstraZeneca’s blockbuster cancer drug, Imfinzi, for the treatment of patients with a type of non-small cell lung cancer on Thursday. The health regulator approved Imfinzi as an additional treatment after surgery in adult patients with non-small cell lung cancer. The drug is already approved in the U.S. for patients with a late-stage form of the disease, where the cancer cannot be removed through surgery.

Immunity 101

Immunity Immunization Chemotherapy 101

pharmaphorum

AUGUST 15, 2024

AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT

Vaccines 111

Vaccines 111

Outsourcing Pharma

AUGUST 15, 2024

Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon.

85

85

pharmaphorum

AUGUST 15, 2024

FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting

102

102

Outsourcing Pharma

AUGUST 15, 2024

Katarina Wikstrom has worked for over 20 years in the field of translational molecular oncology and holds the position of VP global product development at Almac Diagnostic Services.

82

82

pharmaphorum

AUGUST 15, 2024

Large language models (LLMs) find it hard to identify genetic conditions based on patient-written descriptions, say NIH researchers.

107

107

Pharma Times

AUGUST 15, 2024

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023

Vaccines 106

Vaccines 106

EMCrit Project

AUGUST 15, 2024

Getting sued in the maelstrom that is the US malpractice system is horrible!! Let's talk about how to make it better. EMCrit Project by Scott Weingart, MD FCCM.

79

79

BioPharma Dive

AUGUST 15, 2024

The approval of Niktimvo in graft-versus-host disease hands Incyte another immune system-regulating medicine that analysts see as valuable, especially if use is broadened through additional clearances.

Immunity 70

Immunity Immunization 70